195 related articles for article (PubMed ID: 19923573)
1. Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants.
Stoddard MB; Pinto V; Keiser PB; Zollinger W
Clin Vaccine Immunol; 2010 Jan; 17(1):98-107. PubMed ID: 19923573
[TBL] [Abstract][Full Text] [Related]
2. Human monocytoid cell lines as indicators of endotoxin: comparison with rabbit pyrogen and Limulus amoebocyte lysate assay.
Eperon S; De Groote D; Werner-Felmayer G; Jungi TW
J Immunol Methods; 1997 Sep; 207(2):135-45. PubMed ID: 9368640
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
Valentini S; Santoro G; Baffetta F; Franceschi S; Paludi M; Brandini E; Gherardini L; Serruto D; Capecchi B
Vaccine; 2019 Jun; 37(29):3754-3760. PubMed ID: 30448065
[TBL] [Abstract][Full Text] [Related]
4. The expression of endotoxic activity in the Limulus test as compared to cytokine production in immune cells.
Brandenburg K; Howe J; Gutsman T; Garidel P
Curr Med Chem; 2009; 16(21):2653-60. PubMed ID: 19601802
[TBL] [Abstract][Full Text] [Related]
5. Endotoxin contamination in wound dressings made of natural biomaterials.
Nakagawa Y; Murai T; Hasegawa C; Hirata M; Tsuchiya T; Yagami T; Haishima Y
J Biomed Mater Res B Appl Biomater; 2003 Jul; 66(1):347-55. PubMed ID: 12808594
[TBL] [Abstract][Full Text] [Related]
6. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.
Pajon R; Buckwalter CM; Johswich KO; Gray-Owen SD; Granoff DM
Vaccine; 2015 Mar; 33(11):1317-1323. PubMed ID: 25662856
[TBL] [Abstract][Full Text] [Related]
7. Measurements of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usage.
Tsai CM; Frasch CE; Rivera E; Hochstein HD
J Biol Stand; 1989 Jul; 17(3):249-58. PubMed ID: 2477374
[TBL] [Abstract][Full Text] [Related]
8. Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2.
Koeberling O; Giuntini S; Seubert A; Granoff DM
Clin Vaccine Immunol; 2009 Feb; 16(2):156-62. PubMed ID: 19109451
[TBL] [Abstract][Full Text] [Related]
9. Teasing apart structural determinants of 'toxicity' and 'adjuvanticity': implications for meningococcal vaccine development.
Steeghs L; Tommassen J; Leusen JH; van de Winkel JG; van der Ley P
J Endotoxin Res; 2004; 10(2):113-9. PubMed ID: 15120002
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide.
Park CY; Jung SH; Bak JP; Lee SS; Rhee DK
Biologicals; 2005 Sep; 33(3):145-51. PubMed ID: 16055344
[TBL] [Abstract][Full Text] [Related]
11. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity.
Quakyi EK; Hochstein HD; Tsai CM
Infect Immun; 1997 May; 65(5):1972-9. PubMed ID: 9125592
[TBL] [Abstract][Full Text] [Related]
13. Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants.
van der Ley P; van den Dobbelsteen G
Hum Vaccin; 2011 Aug; 7(8):886-90. PubMed ID: 21785281
[TBL] [Abstract][Full Text] [Related]
14. Review of meningococcal group B vaccines.
Granoff DM
Clin Infect Dis; 2010 Mar; 50 Suppl 2(S2):S54-65. PubMed ID: 20144017
[TBL] [Abstract][Full Text] [Related]
15. Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide.
Bjerre A; Brusletto B; Rosenqvist E; Namork E; Kierulf P; Øvstebø R; Joø GB; Brandtzaeg P
J Endotoxin Res; 2000; 6(6):437-45. PubMed ID: 11521068
[TBL] [Abstract][Full Text] [Related]
16. Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production.
Sprong T; Ley Pv; Abdollahi-Roodsaz S; Joosten L; Meer Jv; Netea M; Deuren Mv
Innate Immun; 2011 Dec; 17(6):517-25. PubMed ID: 21088052
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide.
Müller-Alouf H; Alouf JE; Gerlach D; Ozegowski JH; Fitting C; Cavaillon JM
Infect Immun; 1994 Nov; 62(11):4915-21. PubMed ID: 7927772
[TBL] [Abstract][Full Text] [Related]
18. Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharide.
Zariri A; Pupo E; van Riet E; van Putten JP; van der Ley P
Sci Rep; 2016 Nov; 6():36575. PubMed ID: 27841285
[TBL] [Abstract][Full Text] [Related]
19. [Application of the limulus amebocyte lysate test to measurement of endotoxin in therapeutic human plasma protein fraction. Comparison with the rabbit pyrogen test].
Naito S; Fujiwara H; Asakawa S; Homma R; Ishida S; Chino F; Tanaka S; Ohki M; Tsuchiya M; Matsuura S
Yakugaku Zasshi; 1992 Aug; 112(8):551-6. PubMed ID: 1432603
[TBL] [Abstract][Full Text] [Related]
20. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants.
Rossi O; Pesce I; Giannelli C; Aprea S; Caboni M; Citiulo F; Valentini S; Ferlenghi I; MacLennan CA; D'Oro U; Saul A; Gerke C
J Biol Chem; 2014 Sep; 289(36):24922-35. PubMed ID: 25023285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
